Abstracts Archive - Page 537 of 1683 - ATC Abstracts

2020 American Transplant Congress
The State of Interventional Clinical Trials in Solid Organ Transplant: Insights from a Systematic Analysis of Clinicaltrials.gov
A. C. Swaminathan¹, J. Li¹, K. Chiswell¹, W. McManigle¹, I. O’Doherty², W. Fitzsimmons³, J. L. Todd¹, S. Tibbs⁴, S. M. Palmer¹
¹Duke Clinical Research Institute, Durham, NC, ²Critical Path Institute, Tuscan, AZ, ³Fitzsimmons LLC, Chicago, IL, ⁴Duke University, Durham, NC
*Purpose: The approach to immunosuppression after solid organ transplant has remained relatively unchanged for almost 20 years, despite the high prevalence of immunosuppression-related complications and…
2020 American Transplant Congress
The Use of Scribes in Transplant Practice to Achieve Quality Outcomes and Foster Program Development
M. Debroy, K. Chavin
University Hospitals, Cleveland, OH
*Purpose: Transplantation is the most regulated surgical specialty in the US today. Transplant Centers (TC) are an increasingly pivotal component contributing to the fiscal viability…
2020 American Transplant Congress
Increased Transplant Surgery Advanced Practice Provider Involvement Associated with Decreased Hospital Length of Stay and Readmissions Following Kidney Transplantation
E. A. Herriman¹, J. R. Montgomery², K. J. Brown¹, K. J. Woodside¹
¹Surgery-Section of Transplantation, University of Michigan, Ann Arbor, MI, ²Surgery, University of Michigan, Ann Arbor, MI
*Purpose: Transplant surgery Advanced Practice Providers (APPs) are utilized to provide complex care to transplant patients. Daily responsibilities of APPs are broad and variable across…
2020 American Transplant Congress
Waitlisted Patients’ Preferences for Accepting and Consenting to Transplantation with Experimentally Manipulated Organs
E. J. Gordon¹, P. Abt², C. Phillips², F. Bermudez², B. Knopf¹, J. Lee¹, R. Veatch³, R. Knight⁴, P. T. Conway⁴, J. Goldstein⁵, S. Dunn⁶, P. Reese²
¹Northwestern University, Chicago, IL, ²University of Pennsylvania, Philadelphia, PA, ³Georgetown University, Washington, DC, ⁴American Association of Kidney Patients, Tampa, FL, ⁵Lung Transplant Foundation, Raleigh, NC, ⁶Donor Alliance, Denver, CO
*Purpose: Organ donor intervention research (“intervention research”) aims to increase organ quality and quantity for transplantation by protecting against organ injury and enhancing functionality. Given…
2020 American Transplant Congress
Belatacept Based Early Steroid Withdrawal Regimens: Differential Responses in African Americans and Non-African Americans
N. Wilson¹, A. R. Shields², A. L. Christianson¹, S. Tremblay¹, D. Kaufman³, A. Wiseman⁴, J. P. Leone⁵, P. West-Thielke⁶, A. J. Matas⁷, R. R. Alloway¹, E. S. Woodle¹
¹U Cincinnati, Cincinnati, OH, ²The Christ Hospital, Cincinnati, OH, ³U Wisconsin, Madison, WI, ⁴U Colorado, Denver, CO, ⁵Tampa General, Tampa, FL, ⁶U Illinois Chicago, Chicago, IL, ⁷U Minnesota, Minneapolis, MN
*Purpose: Racial disparities in outcomes of kidney transplant recipients (KTxR) are well-described for early steroid withdrawal (ESW) under calcineurin inhibitor (CNI)-based regimens, however little data…
2020 American Transplant Congress
Outreach as a Way to Improve Access to Kidney Transplants: A Model to Align with Future of Kidney Disease Care
A. Govil¹, P. Gudsoorkar¹, C. Siemer², C. King², T. Diwan¹, E. Woodle¹, S. Shah¹, C. V. Thakar¹
¹Univ of Cincinnati, Cincinnati, OH, ²UC Health, Cincinnati, OH
*Purpose: In 2018, there were more than 100,000 patients wait-listed for kidney transplant whereas only around 21,000 patients received a kidney transplant. Increasing access to…
2020 American Transplant Congress
The Impact of Transportation Innovation for Human Organs: Surgical Perspectives and Implications
T. Talaie, S. Niederhaus, E. Villalonga, J. Bromberg, J. Scalea
Transplant Surgery, Unviersity of Maryland Medical Center, Baltimore, MD
*Purpose: Recent changes in allocation and the ongoing organ donor shortage have led to increased regional and national sharing, putting intense pressure on the organ…
2020 American Transplant Congress
Utilization of Direct Acting Oral Anticoagulation in Solid Organ Transplant Patients: A National Survey of Institutional Practices
D. Pierce¹, A. Lichvar¹, D. Salerno², P. Klem³, G. Waldman⁴, J. M. Park⁵
¹University of Illinois at Chicago, Chicago, IL, ²NewYork-Presbyterian Hospital, New York, NY, ³University of Colorado Hospital, Aurora, CO, ⁴Massachusetts General Hospital, Boston, MA, ⁵University of Michigan, Ann Arbor, MI
*Purpose: The safety and efficacy of direct acting oral anticoagulants (DOACs) and reversal strategies are not well established in the solid organ transplant population. This…
2020 American Transplant Congress
Thymoglobulin (ATG) Induction vs. Campath vs. Simulect in DCD Kidneys in UK; Induction Regimes Play a Role after All
A. Asderakis¹, T. Sabbah¹, J. Watkins², L. Szabó¹, D. Elker¹, A. M. Ilham¹, E. Ablorsu¹, M. Stephens¹, U. Khalid¹, R. Chavez¹
¹Cardiff Transplant Unit,, University Hospital of Wales, Cardiff, United Kingdom, ²Infection and Immunity, Cardiff University, Cardiff, United Kingdom
*Purpose: Controlled DCD kidneys have increased dramatically in UK. They suffer from a higher rate of DGF and, often in UK, come from older donors…
2020 American Transplant Congress
Belatacept-Based Regimens: Induction and Recipient Gender Influence Outcomes
N. Wilson¹, A. R. Shields², A. Wiseman³, A. L. Christianson¹, S. Tremblay¹, D. Kaufman⁴, J. P. Leone⁵, A. J. Matas⁶, P. West-Thielke⁷, R. R. Alloway¹, E. S. Woodle¹
¹U Cincinnati, Cincinnati, OH, ²The Christ Hospital, Cincinnati, OH, ³U Colorado, Denver, CO, ⁴U Wisconsin, Madison, WI, ⁵Tampa General, Tampa, FL, ⁶U Minnesota, Minneapolis, MN, ⁷U Illinois Chicago, Chicago, IL
*Purpose: Renal function and adverse event profiles in kidney transplant (KTx) patients under belatacept (BELA) based immunosuppression are significantly improved over calcineurin inhibitors, however BELA…